Benzonatate treats cough from colds, bronchitis, pneumonia, and lung infections. In the U.S., it is sold as Tessalon Perles or Tessalon Capsules.
Recently, the FDA reviewed reports on 31 overdoses of Tessalon, including the deaths of five toddlers. The outcome of the review was a stronger warning on the drug’s label about risks of accidental ingestion resulting in overdose and death in children younger than 10.
The FDA indicated that Tessalon is sold in colored gelcaps with a “candy-like” appearance.